Pier 88 Investment Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $533 | Sell |
310
-126,630
| -100% | -$218K | ﹤0.01% | 104 |
|
|
2025
Q1 | $423K | Buy |
126,940
+72,310
| +132% | +$241K | 0.08% | 89 |
|
|
2024
Q4 | $404K | Buy |
54,630
+10,450
| +24% | +$77.3K | 0.08% | 86 |
|
|
2024
Q3 | $415K | Sell |
44,180
-14,400
| -25% | -$135K | 0.09% | 78 |
|
|
2024
Q2 | $470K | Buy |
58,580
+35,680
| +156% | +$286K | 0.11% | 80 |
|
|
2024
Q1 | $339K | Sell |
22,900
-4,390
| -16% | -$65.1K | 0.08% | 78 |
|
|
2023
Q4 | $222K | Buy |
+27,290
| New | +$222K | 0.06% | 80 |
|
|
2021
Q4 | – | Sell |
-6,650
| Closed | -$164K | – | 117 |
|
|
2021
Q3 | $164K | Buy |
6,650
+5,030
| +310% | +$124K | 0.05% | 106 |
|
|
2021
Q2 | $42K | Sell |
1,620
-15,706
| -91% | -$407K | 0.01% | 110 |
|
|
2021
Q1 | $549K | Sell |
17,326
-3,165
| -15% | -$100K | 0.19% | 89 |
|
|
2020
Q4 | $951K | Sell |
20,491
-19,990
| -49% | -$928K | 0.31% | 71 |
|
|
2020
Q3 | $1.33M | Buy |
40,481
+29,256
| +261% | +$963K | 0.4% | 51 |
|
|
2020
Q2 | $308K | Buy |
11,225
+2,035
| +22% | +$55.8K | 0.09% | 96 |
|
|
2020
Q1 | $275K | Buy |
+9,190
| New | +$275K | 0.1% | 86 |
|